免疫疗法和肝硬化 - 在肝癌中扩大Child-Pugh边界
1University of California, San Francisco, San Francisco, CA, United States.
概括
肝细胞癌 (HCC) 免疫疗法正在扩大. 一些肝功能不佳的患者从组合免疫疗法中受益,挑战历史限制.
科学领域:
- 肝胆道癌症 肝胆道癌症
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 由于安全性和有效性问题,肝细胞癌 (HCC) 治疗传统上不包括肝功能受损的患者.
- 在HCC中,瘤微环境可能具有免疫抑制作用,因肝硬化而加剧,可能导致更糟糕的结果.
研究的目的:
- 评估联合免疫治疗在肝细胞癌 (HCC) 患者,特别是肝功能受损患者的疗效.
主要方法:
- 对临床试验数据和患者结局的审查.
- 在不同HCC患者群体中分析免疫治疗的安全性和有效性概况.
主要成果:
- 肝功能较差的HCC患者的一个子组显示,组合免疫疗法具有显著的临床益处.
- 这一发现挑战了免疫治疗对肝功能良好患者的历史限制.
结论:
- 组合免疫疗法可能为某些肝功能受损的HCC患者提供可行的治疗选择.
- 进一步的研究是有必要的,以扩大免疫疗法在HCC的应用超出目前的资格标准.
相关概念视频
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


